MRA Advisory Group’s Guardant Health GH Stock Holding History

MRA Advisory Group’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.18M	Buy	12,218 +192	+2%	+$31.4K	0.82%	29
2026 Q2	$1.8M	Buy	12,026 +706	+6%	+$76.8K	0.65%	32
2026 Q1	$1.05M	Buy	11,320 +724	+7%	+$72.7K	0.43%	46
2025 Q4	$1.08M	Sell	10,596 -4,761	-31%	-$426K	0.45%	37
2025 Q3	$960K	Sell	15,357 -996	-6%	-$54.2K	0.42%	36
2025 Q2	$851K	Buy	16,353 +1,078	+7%	+$48.1K	0.4%	33
2025 Q1	$651K	Buy	+15,275	New	+$659K	0.35%	41

Other funds holding GH

FFAS

FIG Financial Advisory Services Oklahoma City, Oklahoma $165M AUM 16.79% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return

CPBTD

Central Pacific Bank - Trust Division Honolulu, Hawaii $952M AUM 25.15% 1-Year Est. Return

GAA

Green Alpha Advisors Niwot, Colorado $148M AUM 98.22% 1-Year Est. Return

WoodTrust Financial Wisconsin Rapids, Wisconsin $825M AUM 20.13% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

WWM

Whalen Wealth Management Las Vegas, Nevada $234M AUM 28.06% 1-Year Est. Return

BTWM

Baker Tilly Wealth Management Madison, Wisconsin $510M AUM 18.32% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

MRA Advisory Group's GH Position: Q3 2026 in Review

MRA Advisory Group increased its Guardant Health (GH) stake by 1.6% in Q3 2026, buying an estimated $31.4K and bringing the position to 12,218 shares worth $2.18M. The position accounts for 0.82% of the portfolio, ranked #29.

MRA Advisory Group first reported a position in GH in Q1 2025 and has held it in 7 quarters since. 19 funds tracked by Wall St. Rank hold GH as of Q3 2026.

MRA Advisory Group held 12,218 shares of Guardant Health worth $2.18M as of Q3 2026.
MRA Advisory Group bought 192 Guardant Health shares in Q3 2026, an estimated $31.4K.
Guardant Health made up 0.82% of MRA Advisory Group's portfolio in Q3 2026, its #29 holding.
MRA Advisory Group first reported a position in Guardant Health in Q1 2025 and has held it in 7 quarters since.
19 funds tracked by Wall St. Rank held Guardant Health as of Q3 2026.

Based on MRA Advisory Group's 13F filing for Q3 2026, filed 7 Oct 2026.